510(k) Report

510(k) · Cleared

Cleared

Swift 2.0, Model 132.001

K031158510(k) SpecialCleared Aug 7, 2003118-day reviewClass II21 CFR 892.5700

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Nucletron Corp. · JAQ System, Applicator, Radionuclide, Remote-Controlled

Cleared on Aug 7, 2003 as substantially equivalent to K022739 (Nucletron Corporation, 2002) after a 118-day review. Its family tree reaches back 3 generations to 1991. 3 later devices descend from it.

Decided
Aug 7, 2003
Review
118 days
Class
Class II
Product code
JAQ
Recalls
None
Predicates
1

Its longest line of descent runs back 3 generations to K911612 (1991). 4 ancestors in all. 3 later devices descend from it, 2 citing it directly.

Other ancestors, by year clearedDescendants, by year cleared 1996: 1 other ancestor2011: 1 descendant cleared2008: 1 descendant cleared2017: 1 descendant clearedK911612 · Nucletron Planning System · Nucletron-Oldelft Corp. · 1991K992303 · Sonographic Planning of Oncology Treatments (Spot), Model V.. 1.0 · Nucletron Corp. · 2000K022739 · Real Time HDR (220V), Model 132.001; Real Time HDR (110V), Model 132.002 · Nucletron Corporation · 20021990200020102020
Other ancestors, by generationDescendants, by generation 3 generations back: 1 other ancestor 1 generation forward: 2 descendants2 generations forward: 1 descendant K022739 · Real Time HDR (220V), Model 132.001; Real Time HDR (110V), Model 132.002 · Nucletron Corporation · 2002K992303 · Sonographic Planning of Oncology Treatments (Spot), Model V.. 1.0 · Nucletron Corp. · 2000K911612 · Nucletron Planning System · Nucletron-Oldelft Corp. · 19910
  1. Root · 3 generations backK911612 Nucletron Planning SystemNucletron-Oldelft Corp. · 1991
  2. 2 generations backK992303 Sonographic Planning of Oncology Treatments (Spot), Model V.. 1.0Nucletron Corp. · 2000
  3. 1 generation backK022739 Real Time HDR (220V), Model 132.001; Real Time HDR (110V), Model…Nucletron Corporation · 2002
  4. This deviceK031158 Swift 2.0, Model 132.001Nucletron Corp. · 2003
  5. Descendant · cites it directly · 1 of its ownK112420 Oncentra Prostate 4.0Nucletron · 2011
  6. Descendant · 2 generations on · 0 of its ownK170841 BiopSee, Mobile USMedcom GmbH · 2017
  7. Descendant · cites it directly · 0 of its ownK080929 Oncentra GynNucletron Corporation · 2008

Most influential descendants

Showing 3 of 3 · See all
  • K112420Oncentra Prostate 4.0Nucletron · 2011 · cites it directly1descendant
  • K170841BiopSee, Mobile USMedcom GmbH · 2017 · 2 generations on0descendants
  • K080929Oncentra GynNucletron Corporation · 2008 · cites it directly0descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−3K911612Nucletron Planning SystemNucletron-Oldelft Corp.1991—
−2K992303Sonographic Planning of Oncology Treatments (Spot), Model V.. 1.0Nucletron Corp.2000—
−1K022739Real Time HDR (220V), Model 132.001; Real Time HDR (110V), Model 132.002Nucletron Corporation2002—
0 (this device)K031158Swift 2.0, Model 132.001Nucletron Corp.2003—
+1K112420Oncentra Prostate 4.0Nucletron2011—
+2K170841BiopSee, Mobile USMedcom GmbH2017—
+1K080929Oncentra GynNucletron Corporation2008—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
199610

Descendants by year cleared

Year clearedDevicesWith a Class I recall
200810
201110
201710
FIG. 1 — Lineage of K031158, 1991–2017Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in JAQ? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new JAQ device

  1. #1 K241853 Titanium Fletcher-Style Applicator Set Defined…score 14.9 · 3 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K022739Real Time HDR (220V), Model 132.001; Real Time HDR (110V), Model 132.002
Summary page 2
…on for the specified loading. From this the information the patient can be treated with the dwell positions of the source. Modificationsto the previously cleared device K022739, have been made to add functionality for: 0 Encoder 3D Ultrasound acquisition 3D VOI contouring 3D Catheter recognition I…
Nucletron Corporation2002—

What descends from it? (3)

2 later devices cite it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K112420Oncentra Prostate 4.0Nucletron20111
K080929Oncentra GynNucletron Corporation20080

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 12 years and passes through 3 companies; a new generation was cleared every 2.6 years on median.
  • None of the 4 ancestors has a recall.
  • Of its descendants, K112420 (Nucletron, 2011) has gone furthest, with 1 descendant of its own.

How does its category compare?

All JAQ devices

JAQ System, Applicator, Radionuclide, Remote-Controlled: FDA decisions, review times, recalls and adverse event reports over 20 years.

FDA decisions per year · JAQ

6in 2025

2007: 112008: 102009: 102010: 22011: 22012: 72013: 62014: 72015: 112016: 62017: 72018: 72019: 22020: 42022: 12023: 22024: 102025: 62026 (partial year): 2
2007high 11 (2007) · low 0 (2021)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · JAQ

91in 2025

2007: 48 days median2008: 34 days median2009: 27 days median2012: 89 days median2013: 100 days median2014: 116 days median2015: 183 days median2016: 154 days median2017: 229 days median2018: 252 days median2020: 62 days median2024: 126 days median2025: 91 days median
2007high 252 (2018) · low 27 (2009)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · JAQ

1in 2019

2008: 52009: 12010: 22011: 132012: 52013: 12019: 12026 (partial year): 3
2007high 13 (2011) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · JAQ

3in 2025

2007: 132008: 322009: 352010: 362011: 422012: 342013: 432014: 182015: 72016: 32017: 52018: 22019: 82020: 82021: 52022: 52023: 32024: 12025: 3
2007high 43 (2013) · low 1 (2024)2025

MAUDE reports naming product code JAQ, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20071148013
20081034532
20091027135
20102—236
20112—1342
2012789534
20136100143
20147116018
20151118307
2016615403
2017722905
2018725202
20192—18
202046208
20210—05
20221—05
20232—03
20241012601
202569103
20262—3—

What is it indicated for?

Swift is a software application for Brachytherapy Treatment Planning, for the treatment of cancer, i.e. intercavitary, interstitial, intraluminal, involving radioactive sources.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K031158: Swift 2.0, Model 132.001.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K031158

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026